Composition
- Active ingredients
- TIROFIBAN HYDROCHLORIDE EQ 3.75MG BASE/15ML (EQ 0.25MG BASE/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TIROFIBAN HYDROCHLORIDE EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) · SolutionNDA020913-002 · Prescription
- TIROFIBAN HYDROCHLORIDE EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) · SolutionNDA020913-003 · Prescription
- TIROFIBAN HYDROCHLORIDE EQ 25MG BASE/500ML (EQ 0.05MG BASE/ML) · SolutionNDA020913-001 · Discontinued
- TIROFIBAN HYDROCHLORIDE EQ 3.75MG BASE/15ML (EQ 0.25MG BASE/ML) · SolutionThis page
- TIROFIBAN HYDROCHLORIDE EQ 12.5MG BASE/50ML (EQ 0.25MG BASE/ML) · InjectableNDA020912-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020912.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Aggrastat
- Active substance
- tirofiban hydrochloride
- Route
- Injection
- Dosage form
- Solution
- Applicant
- Medicure
- Status
- Prescription
- FDA approval
- 14 May 1998
- Application
- NDA020912-002